Ninlaro is a prescription cancer drug, used to treat multiple myeloma (bone marrow cancer). To buy Ninlaro or to know its price contact Mehan Biosciences.
Manufacturer : Takeda Pharmaceuticals U.S.A., Inc.
Strengths available : 4 mg
Form :Capsules
Dosage : The recommended starting dose of Ninlaro is 4 mg administered orally once a week on Days 1, 8, and 15 of a 28-day treatment cycle.
Storage :Do not store above 30°C
Is the medicine US FDA approved :Yes
Date of Approval :November 20, 2015
Common side effects are Abdominal or stomach pain, black, tarry stools, bloating or swelling of the face, arms, hands, lower legs, or feet, chills, cough, dark urine, diarrhea, dizziness, fever, headache, itching or rash, light-colored stools, loss of appetite, lower back or side pain, nausea, numbness, tingling, or pain in the hands or feet, painful or difficult urination, pale skin, rapid weight gain, rash with flat lesions or small raised lesions on the skin, redness or discoloration of the skin, sore , throat, tingling of the hands or feet, ulcers, sores, or white spots in the mouth, unpleasant breath odor, unusual bleeding or bruising, unusual tiredness or weakness, unusual weight gain or loss, vomiting of blood, yellow eyes or skin.
Contains 3 packs of 1 hard capsules
Mehan Biosciences is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of Ninlaro Ixazomib 4 mg based in India - To buy Ninlaro Ixazomib 4 mg or know its cost price contact us here.
We supply & sell Ninlaro Ixazomib 4 mg for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.
At MBS, we acknowledge the critical role that reliable sourcing and timely delivery play in the healthcare industry. MBS is your trusted partner in pharmaceutical supply chain management.